Psyence Biomedical Ltd. (PBM)
NASDAQ: PBM · Real-Time Price · USD
2.500
+0.010 (0.40%)
At close: Apr 9, 2026, 4:00 PM EDT
2.540
+0.040 (1.60%)
Pre-market: Apr 10, 2026, 4:25 AM EDT
Psyence Biomedical Market Cap
Psyence Biomedical has a market cap or net worth of $5.73 million as of April 10, 2026. Its market cap has increased by 99.61% in one year.
Market Cap
5.73M
Enterprise Value
-1.42M
1-Year Change
99.61%
Ranking
Category
Stock Price
$2.50
Market Cap Chart
Since December 10, 2021, Psyence Biomedical's market cap has decreased from $323.44M to $5.73M, a decrease of -98.23%. That is a compound annual growth rate of -60.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 9, 2026 | 5.73M | 306.50% |
| Dec 31, 2025 | 1.41M | -84.90% |
| Dec 31, 2024 | 9.34M | -88.49% |
| Dec 29, 2023 | 81.16M | -75.84% |
| Dec 30, 2022 | 335.86M | 3.73% |
| Dec 31, 2021 | 323.77M | 0.10% |
| Dec 10, 2021 | 323.44M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MetaVia | 6.16M |
| XTL Biopharmaceuticals | 6.01M |
| Cardio Diagnostics Holdings | 6.01M |
| Purple Biotech | 5.90M |
| Bio Green Med Solution | 5.80M |
| Addex Therapeutics | 5.77M |
| Artelo Biosciences | 5.75M |
| Mustang Bio | 5.61M |